Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 10, 2024 02:00 ET | Source: Senisca Ltd

SENISCA appoints Tim Edwards as Chair of the Board

Life-science leader with 30 years of experience to guide SENISCA towards becoming a clinical stage novel senotherapeutics company Exeter, UK — 10 September 2024: SENISCA SENISCA, a biotechnology...
March 18, 2024 03:00 ET | Source: Senisca Ltd

SENISCA secures additional £3.7 million financing to support rapid development of senotherapeutic platform to treat age-related disease

SENISCA secures additional £3.7 million financing to support rapid development of senotherapeutic platform to treat age-related disease £3.7 million seed financing supported by consortium of new and...
November 14, 2023 02:00 ET | Source: Senisca Ltd

SENISCA strengthens Board with the appointment of Dr. David Chiswell, Ph.D, OBE as Chairman

SENISCA strengthens Board with the appointment of Dr. David Chiswell, Ph.D, OBE as Chairman Highly experienced biotech veteran to support SENISCA’s rapid development of its senotherapeutic...
November 02, 2023 03:00 ET | Source: Senisca Ltd

SENISCA appoints Dr. Sarah Cole as Chief Executive Officer

SENISCA appoints Dr. Sarah Cole as Chief Executive Officer Exeter, UK — 02 November 2023: SENISCA SENISCA, a biotechnology company developing RNA based therapeutics to reverse cellular senescence and...
May 25, 2023 03:00 ET | Source: Senisca Ltd

SENISCA shortlisted for 2022/2023 Nature Spinoff prize

SENISCA shortlisted for 2022/2023 Nature Spinoff prize Exeter, UK – 25 May 2023: SENISCA, a UK biotechnology company developing RNA based therapeutics to reverse cellular senescence and target the...
April 20, 2023 02:00 ET | Source: Senisca Ltd

SENISCA awarded Innovate UK grant to develop oligonucleotide therapeutics for the treatment of idiopathic pulmonary fibrosis (IPF).

Exeter, UK – 20 April 2023: SENISCA, a biotechnology company developing RNA based therapeutics to reverse cellular senescence and target the diseases of ageing, today announces that it has been...